The Biomolecular Engineering Research Institute said it has used the technique of evolutionary engineering to create a type of catalytic antibody with 10 times greater ability to promote the linking of sugars into sugar chains. The importance of the success lies in the medical world's interest in sugar chains as a starting material for the development of new drugs.